| Vol. 3.27 – 14 July, 2022 |
| |
|
|
| Knockdown of Hsa21-encoded type I interferon receptors, IFNARs, rescued the down syndrome microglial phenotypes both during brain development and in response to pathological tau. [Cell Stem Cell] |
|
|
|
| PUBLICATIONSRanked by the impact factor of the journal |
|
|
|
| Researchers reported a modified human kidney organoid system that generated thousands of similar organoids, each consisting of one-two nephron-like structures. [Cell Stem Cell] |
|
|
|
| The authors reported that interfering with de novo FAS by deletion of the enzyme Acetyl-CoA-Carboxylase 1 inintestinal epithelial cells resulted in the loss of epithelial crypt structures and a specific decline in Lgr5+ intestinal epithelial stem cells. [Nature Communications] |
|
|
|
| Investigators reported a genetically engineered human renal organoid model that recapitulates pleiotropic features of tuberous sclerosis complex (TSC) kidney disease in vitro and upon orthotopic xenotransplantation. [Cell Reports] |
|
|
|
| Scientists developed a 3D-printed islet organoid by combining a pancreatic extracellular matrix and hyaluronic acid methacrylate as specific bioinks. [Acta Biomaterialia] |
|
|
|
| Researchers built a 3D in vitro model system of bone marrow (BM) organoids that recapitulated several structural and cellular components of native BM. [APL Bioengineering] |
|
|
|
| The authors developed 21 patient-derived organoid lines: 12 from metastases, 3 from the liver tumor and 6 from adjacent non-tumor liver. [Stem Cell Reports] |
|
|
|
| Scientists described a robust approach for reproducible engineering of apical-out airway organoid from a defined number of cells. [iScience] |
|
|
|
| Researchers induced human iPSCs to form the embryoid bodies and cerebral organoids with 3D culture. [BMC Pharmacology and Toxicology] |
|
|
|
|
| Investigators highlight recent studies, aided by ex situ systems, which have contributed to significant advances in our understanding of the human lower respiratory tract. [Current Opinion in Genetics & Development] |
|
|
|
|
| Myo Palate is looking tap the synthetic biology expertise of Garton and his team in an effort to reduce the cost of growing muscle cells. The collaboration is funded by a grant provided jointly by Genome Ontario and the Canadian Food Innovation Network. [University of Toronto] |
|
|
|
|
| August 7 – 11, 2022 Treasure Drive, Nova Scotia, Canada |
|
|
|
|
|
| Lehigh University – Bethlehem, Pennsylvania, Untied States |
|
|
|
| The Chinese University of Hong Kong – Hong Kong, China |
|
|
|
| Baylor College of Medicine – Houston, Texas, United States |
|
|
|
| University of British Columbia – Vancouver, British Columbia, Canada |
|
|
|
| Icahn School of Medicine at Mount Sinai – New York, New York, United States |
|
|
|
|